Disease & disorder

classic familial adenomatous polyposis

MONDO:0021055

Familial adenomatous polyposis (FAP) is characterized by the development of hundreds to thousands of adenomas in the rectum and colon during the second decade of life.

Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms16

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Familial adenomatous polyposis

Familial adenomatous polyposis (FAP) is an autosomal dominant inherited condition in which numerous adenomatous polyps form mainly in the epithelium of the large intestine. While these polyps start out benign, malignant transformation into colon cancer occurs when they are left untreated. Besides classical FAP, there is one attenuated FAP variant (originally called hereditary flat adenoma syndrome) are caused by APC gene defects on chromosome 5. While another polyposis-related syndrome, MUTYH-associated polyposis(MAP), is caused by defect in the MUTYH gene on chromosome 1, rather than APC gene. The root cause of FAP is understood to be a genetic mutation—a change in the body's tumour suppressor genes that prevent the development of tumours. The change allows numerous cells of the intestinal wall to develop into potentially cancerous polyps when they would usually reach the end of their life; inevitably, one or more will eventually progress and give rise to cancer (7% risk by age 21, rising to 87% by age 45 and 93% by age 50). These gene changes do not trigger cancer, but rather, they reduce the body's ability to prevent cells from becoming cancerous. Even with the gene change, it may still take time before a cell actually does develop that is cancerous one as a result, and the gene may, in some cases, still partially operate to control tumours. Cancer from FAP takes many years to develop and is almost always an adult-onset disease. The milder form of FAP, known as attenuated familial adenomatous polyposis has the APC gene functional but slightly impaired. It is therefore...

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.